Louis Papageorgiou

745 total citations
50 papers, 429 citations indexed

About

Louis Papageorgiou is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Louis Papageorgiou has authored 50 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 6 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Louis Papageorgiou's work include Cancer-related molecular mechanisms research (5 papers), Endometriosis Research and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Louis Papageorgiou is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Endometriosis Research and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Louis Papageorgiou collaborates with scholars based in Greece, France and Germany. Louis Papageorgiou's co-authors include Dimitriοs Vlachakis, Elias Eliopoulos, Vasileios Megalooikonomou, Σοφία Κοσσίδα, George N. Goulielmos, George P. Chrousos, Flora Bacopoulou, Demetrios�� Spandidos, Eleni Papakonstantinou and Sofia Kossida and has published in prestigious journals such as Journal of Clinical Microbiology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Louis Papageorgiou

46 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis Papageorgiou Greece 13 186 103 79 46 40 50 429
Yimei Jin China 13 218 1.2× 52 0.5× 18 0.2× 55 1.2× 63 1.6× 30 427
Amol Ratnakar Suryawanshi India 14 154 0.8× 150 1.5× 99 1.3× 127 2.8× 27 0.7× 31 495
Xuhui Feng China 8 167 0.9× 37 0.4× 39 0.5× 104 2.3× 32 0.8× 15 397
Uros Midic United States 15 679 3.7× 122 1.2× 39 0.5× 29 0.6× 92 2.3× 35 929
Shunxin Wang China 19 615 3.3× 67 0.7× 90 1.1× 27 0.6× 20 0.5× 42 1.0k
Zhiqiang Yan China 14 316 1.7× 135 1.3× 42 0.5× 79 1.7× 14 0.3× 52 691
Julianna D. Zeidler Brazil 15 240 1.3× 140 1.4× 93 1.2× 93 2.0× 77 1.9× 24 671
Tao Jiao China 11 239 1.3× 24 0.2× 138 1.7× 100 2.2× 81 2.0× 16 485
Elisabeth Guillaume France 11 211 1.1× 41 0.4× 17 0.2× 67 1.5× 26 0.7× 13 400

Countries citing papers authored by Louis Papageorgiou

Since Specialization
Citations

This map shows the geographic impact of Louis Papageorgiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Papageorgiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Papageorgiou more than expected).

Fields of papers citing papers by Louis Papageorgiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Papageorgiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Papageorgiou. The network helps show where Louis Papageorgiou may publish in the future.

Co-authorship network of co-authors of Louis Papageorgiou

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Papageorgiou. A scholar is included among the top collaborators of Louis Papageorgiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Papageorgiou. Louis Papageorgiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papageorgiou, Louis, Eleni Papakonstantinou, Dimitrios Chaniotis, et al.. (2024). SNP and Structural Study of the Notch Superfamily Provides Insights and Novel Pharmacological Targets against the CADASIL Syndrome and Neurodegenerative Diseases. Genes. 15(5). 529–529. 1 indexed citations
2.
Papageorgiou, Louis, et al.. (2023). AB0002 THE GENETIC BACKGROUND OF ANKYLOSING SPONDYLITIS INDICATES A STRONG CORRELATION WITH OTHER AUTOIMMUNE DISEASES. Annals of the Rheumatic Diseases. 82. 1179–1180. 1 indexed citations
3.
Papageorgiou, Louis, Eleni Papakonstantinou, Flora Bacopoulou, et al.. (2023). An Updated Evolutionary and Structural Study of TBK1 Reveals Highly Conserved Motifs as Potential Pharmacological Targets in Neurodegenerative Diseases. Advances in experimental medicine and biology. 1423. 41–57. 1 indexed citations
4.
Vazgiourakis, Vasileios, Maria I. Zervou, Louis Papageorgiou, et al.. (2023). Association of endometriosis with cardiovascular disease: Genetic aspects (Review). International Journal of Molecular Medicine. 51(3). 20 indexed citations
5.
Papageorgiou, Louis, et al.. (2023). A global population genomic analysis shows novel insights into the genetic characteristics of endometriosis. World Academy of Sciences Journal. 5(2). 4 indexed citations
6.
Papageorgiou, Louis, Eleni Papakonstantinou, Flora Bacopoulou, et al.. (2023). ADRA2B and HTR1A: An Updated Study of the Biogenic Amine Receptors Reveals Novel Conserved Motifs Which Play Key Role in Mental Disorders. Advances in experimental medicine and biology. 1423. 79–99. 2 indexed citations
7.
Papageorgiou, Louis, Eleni Papakonstantinou, Stefanos Leptidis, et al.. (2022). Role of microRNAs and long non‑coding RNAs in glucocorticoid signaling (Review). International Journal of Molecular Medicine. 50(6). 6 indexed citations
8.
Papakonstantinou, Eleni, Louis Papageorgiou, Demetrios�� Spandidos, et al.. (2022). Multiple sclerosis and computational biology (Review). Biomedical Reports. 17(6). 96–96. 8 indexed citations
9.
Papageorgiou, Louis, et al.. (2021). Hippo(crates): An integrated atlas for natural product exploration through a state‑of‑the art pipeline in chemoinformatics. World Academy of Sciences Journal. 4(1). 2 indexed citations
10.
Papageorgiou, Louis, et al.. (2021). POS0350 EPIONE APPLICATION: AN INTEGRATED GENOTYPE ANALYSIS WEB SERVER FOR CLINICAL GENOMICS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). Annals of the Rheumatic Diseases. 80. 405–405. 1 indexed citations
11.
Papageorgiou, Louis, Αspasia Efthimiadou, Flora Bacopoulou, et al.. (2021). Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review). Molecular Medicine Reports. 24(1). 6 indexed citations
13.
14.
Koumandou, Vassiliki Lila, et al.. (2020). Microbiome Hijacking Towards an Integrative Pest Management Pipeline. Advances in experimental medicine and biology. 1195. 21–32. 2 indexed citations
15.
Papageorgiou, Louis, et al.. (2018). Human Emotions on the Onset of Cardiovascular and Small Vessel Related Diseases. In Vivo. 32(4). 859–870. 9 indexed citations
16.
Papageorgiou, Louis, Vasileios Megalooikonomou, & Dimitriοs Vlachakis. (2017). Genetic and structural study of DNA-directed RNA polymerase II of Trypanosoma brucei , towards the designing of novel antiparasitic agents. PeerJ. 5. e3061–e3061. 11 indexed citations
18.
Papageorgiou, Louis, et al.. (2015). Antibodies as stratagems against cancer. Molecular BioSystems. 12(7). 2047–2055. 6 indexed citations
19.
Papageorgiou, Louis, et al.. (2014). Ebola virus epidemic: a deliberate accident?. PubMed Central. 3(3). 72–76. 5 indexed citations
20.
Papageorgiou, Louis, et al.. (2014). Molecular dynamics simulations through GPU video games technologies.. PubMed. 3(2). 64–71. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026